An Introduction to Minimally Invasive Pediatric Epilepsy Surgery

Abstract

The field of minimally invasive surgery has evolved over the past 50 years, including neurosurgery, with an evolution to “minimally invasive neurosurgery” when feasible. Epilepsy surgery has followed this trend, with a transition from standard neurosurgical techniques to minimally invasive techniques in all phases of neurosurgical involvement. These include the diagnostic intracranial electroencephalogram with a subdural exploration to stereoelectroencephalography, the actual resection from an open craniotomy to a less destructive technique, or the multiple modalities of neuromodulation instead of a destructive surgery.

The influence of these minimally invasive techniques has resulted in a change in the overall philosophy of pediatric epilepsy surgery. The expectations of what is considered “successful” epilepsy surgery has changed from total seizure control, in other words, a “cure,” to palliative epilepsy surgery with a decrease in the targeted seizures, especially “disabling seizures.” This has led to an overall greater acceptance of epilepsy surgery. This article summarizes the major reasons behind the explosion of minimally invasive pediatric epilepsy surgery, which are amplified in the subsequent articles. Some of this chapter includes the authors' opinions.

Keywords

pediatric epilepsy surgery - epilepsy

Publication History

Received: 12 November 2022

Accepted: 12 November 2022

Article published online:
22 December 2022

• References

• 1 Gadgil N, Muir M, Lopresti MA, Lam SK. An update on pediatric surgical epilepsy: Part II. Surg Neurol Int 2019; 10 (258) 258
• 2 Treiber JM, Curry DJ, Weiner HL, Roth J. Epilepsy surgery in tuberous sclerosis complex (TSC): emerging techniques and redefinition of treatment goals. Childs Nerv Syst 2020; 36 (10) 2519-2525
• 3 Matern TS, DeCarlo R, Ciliberto MA, Singh RK. Palliative epilepsy surgery procedures in children. Semin Pediatr Neurol 2021; 39: 100912
• 4 Ravindra VM, Karas PJ, Lazarro TT. et al. Epilepsy surgery in young children with tuberous sclerosis complex: a novel hybrid multimodal surgical approach. Neurosurgery (accepted for publication)
• 5 Jehi L. The epileptogenic zone: concept and definition. Epilepsy Curr 2018; 18 (01) 12-16
• 6 Wilfong AA, Curry DJ. Hypothalamic hamartomas: optimal approach to clinical evaluation and diagnosis. Epilepsia 2013; 54 (Suppl. 09) 109-114
• 7 Ravindra VM, Lee S, Gonda D. et al. Magnetic resonance-guided laser interstitial thermal therapy for pediatric periventricular nodular heterotopia-related epilepsy. J Neurosurg Pediatr 2021; 28: 657-662
• 8 Moshel YA, Elliott R, Teutonico F. et al. Do tubers contain function? Resection of epileptogenic foci in perirolandic cortex in children with tuberous sclerosis complex. Epilepsia 2010; 51 (07) 1242-1251
• 9 Cross JH, Jayakar P, Nordli D. et al; International League against Epilepsy, Subcommission for Paediatric Epilepsy Surgery, Commissions of Neurosurgery and Paediatrics. Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia 2006; 47 (06) 952-959
• 10 Solli E, Colwell NA, Say I. et al. Deciphering the surgical treatment gap for drug-resistant epilepsy (DRE): a literature review. Epilepsia 2020; 61 (07) 1352-1364
• 11 Samanta D, Hoyt ML, Perry MS. Parental experience and decision-making for epilepsy surgery: a systematic review of qualitative and quantitative studies. Epilepsy Behav 2021; 123: 108263
• 12 Samanta D, Leigh Hoyt M, Scott Perry M. Healthcare professionals' knowledge, attitude, and perception of epilepsy surgery: a systematic review. Epilepsy Behav 2021; 122: 108199
• 13 Samanta D, Ostendorf AP, Willis E. et al. Underutilization of epilepsy surgery: Part I: A scoping review of barriers. Epilepsy Behav 2021; 117: 107837
• 14 Berg AT, Zelko FA, Levy SR, Testa FM. Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes: a prospective cohort study. Neurology 2012; 79 (13) 1384-1391
• 15 Dwivedi R, Ramanujam B, Chandra PS. et al. Surgery for drug-resistant epilepsy in children. N Engl J Med 2017; 377 (17) 1639-1647
• 16 Accogli A, Addour-Boudrahem N, Srour M. Neurogenesis, neuronal migration, and axon guidance. In: Gallagher A, Bulteau C, Cohen D, Michaud JJ. eds. Handbook of Clinical Neurology. 2020. 173: 25-42 https://doi.org/10.1016/B978-0-444-64150-2.00004-6
• 17 Ismail FY, Ljubisavljevic MR, Johnston MV. A conceptual framework for plasticity in the developing brain. Handb Clin Neurol 2020; 173: 57-66
• 18 Stefovska VG, Uckermann O, Czuczwar M. et al. Sedative and anticonvulsant drugs suppress postnatal neurogenesis. Ann Neurol 2008; 64 (04) 434-445
• 19 Ikonomidou C. Triggers of apoptosis in the immature brain. Brain Dev 2009; 31 (07) 488-492
• 20 Boshuisen K, van Schooneveld MMJ, Uiterwaal CSPM. et al; TimeToStop cognitive outcome study group. Intelligence quotient improves after antiepileptic drug withdrawal following pediatric epilepsy surgery. Ann Neurol 2015; 78 (01) 104-114
• 21 Mikati MA, Andermann F, Comair YC. et al. Indications and timing of surgery of catastrophic. In: Luders HO, Comair YG. eds. Epilepsy Surgery. 2nd ed.. Philadelphia: Lippincott, Williams, Wilkins, Philadelphia; 2001: 1034-1038
• 22 Holmes GL, Gairsa JL, Chevassus-Au-Louis N, Ben-Ari Y. Consequences of neonatal seizures in the rat: morphological and behavioral effects. Ann Neurol 1998; 44 (06) 845-857
• 23 Howell KB, Harvey AS, Archer JS. Epileptic encephalopathy: Use and misuse of a clinically and conceptually important concept. Epilepsia 2016; 57 (03) 343-347
• 24 Akman CI, Riviello JJ. Intractable epilepsy in children and selection of surgical candidates. In: Oguz Cataltepe and George I. Jallo, eds. Pediatric Epilepsy Surgery: Preoperative Assessment and Surgical Treatment. 2nd ed.. New York: Thieme; 2020: 81-91
• 25 Zlokovic BV, Apuzzo ML. Cellular and molecular neurosurgery: pathways from concept to reality–part I: target disorders and concept approaches to gene therapy of the central nervous system. Neurosurgery 1997; 40 (04) 789-803 , discussion 803–804
• 26 White E. Molecular neurosurgery: vectors and vector delivery strategies. Br J Neurosurg 2012; 26 (06) 798-808
• 27 Cook M, Murphy M, Bulluss K. et al. Anti-seizure therapy with a long-term, implanted intra-cerebroventricular delivery system for drug-resistant epilepsy: a first-in-man study. EClinicalMedicine 2020; 22: 100326
• 28 Mendell JR, Al-Zaidy S, Shell R. et al. Single-dose gene replacement therapy for spinal muscular atrophy. N Engl J Med 2017; 377 (18) 1713-1722
• 29 Finkel RS, Mercuri E, Darras BT. et al; ENDEAR Study Group. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 2017; 377 (18) 1723-1732
• 30 Baranello G, Darras BT, Day JW. et al; FIREFISH Working Group. Risdiplam in Type 1 spinal muscular atrophy. N Engl J Med 2021; 384 (10) 915-923
• 31 Hwu WL, Muramatsu S, Tseng SH. et al. Gene therapy for aromatic L-amino acid decarboxylase deficiency. Sci Transl Med 2012; 4 (134) 134ra61
• 32 Kojima K, Nakajima T, Taga N. et al. Gene therapy improves motor and mental function of aromatic l-amino acid decarboxylase deficiency. Brain 2019; 142 (02) 322-333
• 33 Pearson TS, Gupta N, Sebastian WS. et al. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. Nat Com 2021; ;Jul 12; 12 (01) 4251
• 34 Han Z, Chen C, Christiansen A. et al. Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome. Sci Transl Med 2020; 12 (558) eaaz6100